Literature DB >> 8674165

Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations.

J Ma1, G Stoter, J Verweij, J H Schellens.   

Abstract

Sample preparation for the measurement of non-protein-bound platinum was evaluated by precipitation of plasma proteins with cold ethanol. The method was compared with the routinely used plasma ultrafiltration and with trichloroacetic acid (TCA) protein precipitation. After incubation of human plasma samples with cisplatin or carboplatin, unbound platinum concentrations were determined applying Amicon Diaflo ultrafiltration membranes and Millipore ultrafree-MC filters. For protein precipitation, 1 ml of cold (-20 degrees C) pure ethanol was added to 0.5 ml of human plasma and the supernatant was collected after 2 h, or 0.5 ml of cold 20% TCA was added to 0.5 ml of plasma. Platinum was analyzed by atomic absorption spectrophotometry (AAS). There was no significant difference between the ethanol and ultrafiltration methods in the unbound platinum concentration. The protein content in the supernatant (1.00 +/- 0.20%) was slightly higher than that in the Amicon (0.58 +/- 0.05%) and Millipore (0.55 +/- 0.04%) ultrafiltrates. On average, the TCA and ethanol method seemed to be equally appropriate. The ethanol precipitation method is concluded to be simple, convenient, and reproducible and has negligible costs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674165     DOI: 10.1007/s002800050501

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  8 in total

1.  Conjugate addition/cyclization sequence enables selective and simultaneous fluorescence detection of cysteine and homocysteine.

Authors:  Xiaofeng Yang; Yixing Guo; Robert M Strongin
Journal:  Angew Chem Int Ed Engl       Date:  2011-09-20       Impact factor: 15.336

2.  Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.

Authors:  Inge R H M Konings; Frederike K Engels; Stefan Sleijfer; Jaap Verweij; Erik A C Wiemer; Walter J Loos
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-20       Impact factor: 3.333

3.  Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.

Authors:  Ryan M Franke; Ashley M Kosloske; Cynthia S Lancaster; Kelly K Filipski; Chaoxin Hu; Oliver Zolk; Ron H Mathijssen; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2010-07-02       Impact factor: 12.531

4.  Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.

Authors:  Claudia Schmidt; Bianka Karge; Rainer Misgeld; Aram Prokop; Mark Brönstrup; Ingo Ott
Journal:  Medchemcomm       Date:  2017-06-27       Impact factor: 3.597

5.  Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients.

Authors:  Mustafa E Ibrahim; Cara Chang; Yichun Hu; Susan L Hogan; Nickie Mercke; Madeleine Gomez; Cindy L O'Bryant; Daniel W Bowles; Blessy George; Xia Wen; Brian Buckley; Lauren Aleksunes; Melanie S Joy
Journal:  Eur J Clin Pharmacol       Date:  2018-09-15       Impact factor: 2.953

6.  Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients.

Authors:  Sara Folkesson Hansson; Maja Puchades; Kaj Blennow; Magnus Sjögren; Pia Davidsson
Journal:  Proteome Sci       Date:  2004-11-18       Impact factor: 2.480

7.  Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.

Authors:  Mirjam E van de Velde; Emil den Bakker; Hester N Blufpand; Gertjan L Kaspers; Floor C H Abbink; Arjenne W A Kors; Abraham J Wilhelm; Richard J Honeywell; Godefridus J Peters; Birgit Stoffel-Wagner; Laurien M Buffart; Arend Bökenkamp
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

8.  In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum.

Authors:  Luis Ariel Espinosa; Yassel Ramos; Ivan Andújar; Enso Onill Torres; Gleysin Cabrera; Alejandro Martín; Diamilé Roche; Glay Chinea; Mónica Becquet; Isabel González; Camila Canaán-Haden; Elías Nelson; Gertrudis Rojas; Beatriz Pérez-Massón; Dayana Pérez-Martínez; Tamy Boggiano; Julio Palacio; Sum Lai Lozada Chang; Lourdes Hernández; Kathya Rashida de la Luz Hernández; Saloheimo Markku; Marika Vitikainen; Yury Valdés-Balbín; Darielys Santana-Medero; Daniel G Rivera; Vicente Vérez-Bencomo; Mark Emalfarb; Ronen Tchelet; Gerardo Guillén; Miladys Limonta; Eulogio Pimentel; Marta Ayala; Vladimir Besada; Luis Javier González
Journal:  Anal Bioanal Chem       Date:  2021-11-05       Impact factor: 4.478

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.